Renowned Silicon Valley investor: SpaceX is a must-buy and must-hold future bet for institutional investors
BlockBeats reported that on June 16, in the latest episode of the BG2 podcast, Brad Gerstner described SpaceX as a "must buy, must hold" asset for institutional investors, reasoning that the company simultaneously sits at the forefront of both the space economy and the expansion of artificial intelligence computing power.
BG2 is a Silicon Valley investment community podcast focused on technology, markets, investment, and capitalism. It is hosted by Altimeter founder and CEO Brad Gerstner and former Benchmark General Partner Bill Gurley. Gerstner himself is a technology growth stock investor who has long focused on cloud computing, AI, and high-growth technology companies.
Gerstner stated that if investors believe in the direction of AGI, they must accept the premise that the scale of computing power required worldwide will far exceed current market expectations, and the economic value created by large models in the future will surpass most people's imagination. In his view, combining this assessment with SpaceX's core business makes it difficult to find another company or entrepreneur that offers a more direct future bet.
Regarding disputes over the valuation of a potential IPO, Gerstner said that skeptics are focused on SpaceX’s revenue from last year and investment banks' forecasts of substantial revenue growth over the next three years, questioning whether many companies can achieve several-fold expansion in three to four years.
However, he believes that if you break down the business using first principles, Starlink, ground-based AI computing power, and the model business after the Cursor acquisition all could support this growth trajectory. Gerstner also mentioned that after SpaceX signed new deals, its valuation multiple dropped from about 100 times past revenue to approximately 39 times, and noted that the company added about $29 billion in new orders within a month, which he considers extremely rare.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
A key leap toward the internationalization of the Korean won: The Bank of Korea launches a trial run of its 24/7 international settlement system, with full deployment set for January next year.
The Bank of Korea officially launched the trial operation of the "BOK Won International Payment Network" on Monday local time.
Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD
Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Crypto prices
More
